4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†.

• Cardoso F European School of Oncology (ESO), European Society for Medical Oncology (ESMO) and Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt.
• Senkus E European Society for Medical Oncology (ESMO) and Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
• Costa A European School of Oncology, Milan, Italy.
• Papadopoulos E Europa Donna Cyprus, Nicosia, Cyprus.
• Aapro M Oncology Department, Clinique de Genolier, Genolier, Switzerland.
• André F Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
• Harbeck N Breast Centre, Department of Obstetrics and Gynaecology, University of Munich (LMU), Munich, Germany.
• Aguilar Lopez B Direction Office, ULACCAM (Union Latinoamericana Contra el Cáncer de la Mujer), Mexico DF, Mexico.
• Barrios CH Department of Oncology, PURCS School of Medicine, Porto Alegre, Brazil.
• Bergh J Department of Oncology-Pathology, Karolinska Institute & University Hospital, Stockholm, Sweden.
• Biganzoli L European Society of Breast Cancer Specialists (EUSOMA) and Department of Medical Oncology, Nuovo Ospedale di Prato - Istituto Toscano Tumori, Prato, Italy.
• Boers-Doets CB CB Boers Organization, Wormer, The Netherlands.
• Cardoso MJ Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation and Nova Medical School, Lisbon, Portugal.
• Carey LA Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA.
• Cortés J Department of Oncology, Vall d' Hebron University, Barcelona, Spain.
• Curigliano G Division of Early Drug Development, Department of Oncology and Hemato-Oncology, European Institute of Oncology, University of Milano, Milano, Italy.
• Diéras V Gynaecology and Breast Department, Centre Eugène Marquis, Rennes, France.
• El Saghir NS Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon.
• Eniu A Breast Cancer Department, Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania.
• Fallowfield L SHORE-C, Brighton & Sussex Medical School, University of Sussex, Brighton, UK.
• Francis PA Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
• Gelmon K Medical Oncology Department, BC Cancer Agency, Vancouver, Canada.
• Johnston SRD Department of Medicine, The Royal Marsden, Sutton, UK.
• Kaufman B Department of Oncology, Sheba Medical Center, Ramat Gan, Israel.
• Koppikar S Department of Medical Oncology, Bombay Hospital Institute of Medical Sciences, Mumbai, India.
• Krop IE Breast Oncology Center Dana-Farber Cancer Institute, Boston, USA.
• Mayer M Advanced BC.org, New York, USA.
• Nakigudde G Advocacy Department, UWOCASO (Uganda Women's Cancer Support Organization), Kampala, Uganda.
• Offersen BV European Society of Radiation Oncology (ESTRO) and Department of Experimental Clinical Oncology & Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
• Ohno S Cancer Institute Hospital, Breast Oncology Centre, Tokyo, Japan.
• Pagani O Institute of Oncology of Southern Switzerland, Geneva University Hospitals, Swiss Group for Clinical Cancer Research (SAKK), International Breast Cancer Study Group (IBCSG), Bellinzona, Switzerland.
• Paluch-Shimon S Oncology Institute, Shaare Zedek Medical Centre, Jerusalem, Israel.
• Penault-Llorca F Department of Pathology, Centre Jean Perrin, Clermont-Ferrand Cedex, France.
• Prat A IDIBAPS (Institut d'Investigacions Biomèdiques August Pi iSunyer), Hospital Clínic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumor, Barcelona, Spain.
• Rugo HS Breast Oncology Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
• Sledge GW Oncology Division, Stanford University Medical Center, Stanford, USA.
• Spence D Policy Department, Breast Cancer Network Australia, Camberwell, VIC, Australia.
• Thomssen C Department of Gynaecology, Martin Luther University Halle-Wittenburg, Halle, Germany.
• Vorobiof DA Oncology Department, Sandton Oncology Centre, Johannesburg, South Africa.
• Xu B Department of Medical Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China.
• Norton L Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York.
• Winer EP Dana-Farber Cancer Institute, Susan Smith Center for Women's Cancers, Breast Oncology Center, Boston, USA.

Show more…

Biomarkers, Tumor

Biopsy, Large-Core Needle

Breast

Breast Neoplasms

Chemoradiotherapy, Adjuvant

Clinical Trials as Topic

Consensus Development Conferences as Topic

Europe

Evidence-Based Medicine

Female

Humans

Integrative Medicine

Mastectomy

Medical Oncology

Neoadjuvant Therapy

Neoplasm Staging

Societies, Medical

Treatment Outcome